Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
Current Assets:
Cash and cash equivalents	$ 122,802	$ 121,038
Restricted cash	301	300
Short-term investments	163,785	173,182
Accounts receivable, net	127,309	122,279
Inventory	184,703	166,048
Prepaid and other current assets	29,434	12,552
Total current assets	628,334	595,399
Property, plant and equipment, net	13	16
Long-term inventory	9,106	64,740
Operating lease right-of-use asset	7,186	7,592
Other long-term assets	1,109	1,213
Intangible asset, net	14,066	16,389
TOTAL ASSETS	659,814	685,349
Current Liabilities:
Accounts payable	36,712	40,366
Accrued expenses and other current liabilities	145,521	139,583
Total current liabilities	182,233	179,949
Long-Term Liabilities:
Long-term operating lease liability	6,731	7,723
Other long-term liabilities	11,956	11,501
Total liabilities	200,920	199,173
Commitments and contingencies (Note 5)
Stockholders’ Equity:
Ordinary Shares, GBP 0.50 par value per share, unlimited authorized; 429,597,419 shares issued, 415,965,977 shares outstanding as of September 30, 2025; 422,256,900 shares issued, 411,584,851 shares outstanding as of December 31, 2024	310,019	305,298
Additional paid-in capital	1,922,351	1,914,750
Treasury stock; 13,631,442 shares as of September 30, 2025: 10,672,049 shares as of December 31, 2024	(67,356)	(65,326)
Accumulated deficit	(1,706,120)	(1,668,546)
Total stockholders’ equity	458,894	486,176
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 659,814	$ 685,349